Early findings show new drug could be ‘gamechanging’ for brain cancer treatment
Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent
Continue ReadingUsing ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent
Continue Reading
Join the Discussion